Verona Pharma plc (VRNA) Reports In-Line Q3 EPS
Tweet
Share
E-mailGet Alerts VRNA Hot Sheet
Join SI Premium – FREE
Verona Pharma plc (NASDAQ: VRNA) reported Q3 EPS of ($0.07), in-line with the analyst estimate of ($0.07).
For earnings history and earnings-related data on Verona Pharma plc (VRNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rockstar Energy founder seeks CEO role at Celsius Holdings
- Soligenix, Inc. (SNGX) Tops Q2 EPS by 8c
- Evommune, Inc. (EVMN) Misses Q2 EPS by 20c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
